Latest News from: Yale Cancer Center

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 226
Newswise: Researchers show genetic mutations in advanced lung cancer may predict improved outcomes

Article ID: 719728

Researchers show genetic mutations in advanced lung cancer may predict improved outcomes

Yale Cancer Center

According to new findings by Yale Cancer Center scientists, higher levels of genetic mutations in a tumor biopsy are linked to improved clinical outcomes in patients using pembrolizumab (Keytruda) to treat non-small cell lung cancer (NSCLC).

Released:
27-Sep-2019 12:00 PM EDT
Newswise: Yale Cancer Center Research Highlighted at ASTRO 2019

Article ID: 719137

Yale Cancer Center Research Highlighted at ASTRO 2019

Yale Cancer Center

Yale Cancer Center (YCC) scientists presented research at the 61st annual American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.

Released:
17-Sep-2019 6:00 PM EDT

Article ID: 719135

Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer

Yale Cancer Center

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).

Released:
17-Sep-2019 3:55 PM EDT
Newswise: Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer

Article ID: 717869

Yale Cancer Center finding offers hope for treatment of incurable Childhood Brain cancer

Yale Cancer Center

A team of investigators at Yale Cancer Center (YCC) have found a major chink in the armor of an incurable childhood brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG).

Released:
22-Aug-2019 11:10 AM EDT
Newswise: Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

Article ID: 713795

Yale Cancer Center researchers demonstrate novel drug increased survival for patients with bladder cancer.

Yale Cancer Center

There are no approved treatment options for patients with advanced bladder cancer after standard chemotherapy and immune treatments, but the results of a phase II clinical trial led by Yale Cancer Center and Smilow Cancer Hospital researchers demonstrates an effective treatment for this deadly disease.

Released:
3-Jun-2019 7:30 AM EDT
Newswise: New Technique by Yale Cancer Center Scientists May Improve Detection and Treatment of Advanced Brain Cancer

Article ID: 712009

New Technique by Yale Cancer Center Scientists May Improve Detection and Treatment of Advanced Brain Cancer

Yale Cancer Center

In a new study, Yale Cancer Center scientists have demonstrated a powerful method to analyze how tumor cells are altered as they metastasize to the brain.

Released:
29-Apr-2019 8:00 AM EDT
Newswise: Smilow Cancer Hospital and Yale Cancer Center receive grant from Frederick A. DeLuca Foundation to fund Hematology Research Center

Article ID: 711845

Smilow Cancer Hospital and Yale Cancer Center receive grant from Frederick A. DeLuca Foundation to fund Hematology Research Center

Yale Cancer Center

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) are proud to announce a five-year grant awarded by The Frederick A. DeLuca Foundation to establish The DeLuca Center for Innovation in Hematology Research.

Released:
24-Apr-2019 12:30 PM EDT
Newswise: Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy

Article ID: 710389

Smilow Cancer Hospital first in Connecticut to perform CAR T-cell therapy

Yale Cancer Center

One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital. CAR T-cell therapy is groundbreaking immunotherapy that can cure patients with certain blood cancers who have run out of treatment options.

Released:
28-Mar-2019 1:05 PM EDT
Newswise: Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Article ID: 708321

Yale Cancer Center researchers combine targeted therapies to fight head and neck cancers

Yale Cancer Center

Yale Cancer Center researchers have identified a potential therapy that combines two types of molecularly targeted drugs to produce a synergistic effect against head and neck cancer.

Released:
19-Feb-2019 2:20 PM EST
Newswise: Yale Cancer Center scientists advise caution in immunotherapy research
  • Embargo expired:
    20-Dec-2018 11:00 AM EST

Article ID: 705690

Yale Cancer Center scientists advise caution in immunotherapy research

Yale Cancer Center

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer immunotherapy grows exponentially, some caution should be exercised as we continue to better understand the biology of these new therapeutic targets.

Released:
19-Dec-2018 12:05 PM EST

Showing results

110 of 226

Chat now!